AI
EBS icon

AdvisorShares Investments’s Emergent Biosolutions EBS Stock Holding History

AdvisorShares Investments’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,900
Closed -$493K – 288
2025
Q4 		$493K Buy
+39,900
New +$428K 0.08% 116

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AdvisorShares Investments's EBS Position: Q1 2026 in Review

AdvisorShares Investments sold out of Emergent Biosolutions (EBS) in Q1 2026, closing a stake of 39,900 shares — an estimated $493K sold.

AdvisorShares Investments first reported a position in EBS in Q4 2025 and held it in 1 quarter. The position peaked at $493K in Q4 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • AdvisorShares Investments reported no remaining Emergent Biosolutions position as of Q1 2026 after selling out during the quarter.
  • AdvisorShares Investments sold 39,900 Emergent Biosolutions shares in Q1 2026, an estimated $493K.
  • AdvisorShares Investments first reported a position in Emergent Biosolutions in Q4 2025 and held it in 1 quarter.
  • AdvisorShares Investments's Emergent Biosolutions position peaked at $493K in Q4 2025.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on AdvisorShares Investments's 13F filing for Q1 2026, filed 28 Apr 2026.